You are here

Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone HCl Controlled-Release in Chinese Patients with Cancer Pain: A Phase 3, Randomized, Double-Blind, Multi-Center Study.